Search results for “Glatiramer acetate” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 854 patents, we discovered top 51 key players by total patent application. Teva Pharmaceutical Industries Ltd., Yeda Research & Development Co. Ltd., Mapi-Pharma Ltd. are dominant in this area. They take 61.83% of the total patent filing.
Teva Pharmaceutical Industries Ltd.
Israel
Patent: 330
Yeda Research & Development Co. Ltd.
Israel
Patent: 132
Mapi-Pharma Ltd.
Israel
Patent: 66
Momenta Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 38
TEVA PHARMS USA
New Jersey, United States
Patent: 33
Hybio Pharmaceutical Co.. Ltd.
Guangdong Sheng, China
Patent: 29
Dr. Reddy's Laboratories Ltd.
Andhra Pradesh, India
Patent: 26
Mylan, Inc.
Pennsylvania, United States
Patent: 23
ID Biomedical Corporation of Quebec
Canada
Patent: 23
ScinoPharm Taiwan Ltd.
Taiwan Province, China
Patent: 18
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 55 patents applied in the last 5 years. We discover 16 most active companies in this area. The fast-growing Mapi-Pharma Ltd., Institut Pasteur, Yeda Research & Development Co. Ltd. take 54.55% of patent filing during this period.
Mapi-Pharma Ltd.
Israel
Patent: 16
Institut Pasteur
France
Patent: 8
Yeda Research & Development Co. Ltd.
Israel
Patent: 6
Changsha Yingnaifa Pharmaceutical Co., Ltd.
Hunan Sheng, China
Patent: 2
Momenta Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 2
Alembic Pharmaceuticals Ltd.
Gujarat, India
Patent: 2
University of Maryland Greenebaum Cancer Center
United States
Patent: 2
Mylan, Inc.
Pennsylvania, United States
Patent: 2
Hybio Pharmaceutical Co.. Ltd.
Guangdong Sheng, China
Patent: 2
Suzhou Rongxi Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 55 patents in last 5 years, we discover 9 new entrants. Institut Pasteur, Changsha Yingnaifa Pharmaceutical Co., Ltd., Suzhou Rongxi Biotechnology Co., Ltd. are the most active new entrants in this area.
Institut Pasteur
France
Patent: 8
Changsha Yingnaifa Pharmaceutical Co., Ltd.
Hunan Sheng, China
Patent: 2
Suzhou Rongxi Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Alembic Pharmaceuticals Ltd.
Gujarat, India
Patent: 2
University of Maryland Greenebaum Cancer Center
United States
Patent: 2
Productos Maver SA de CV
Mexico
Patent: 1
Hanyu Pharmaceutical (Wuhan) Co., Ltd.
Hubei Sheng, China
Patent: 1
Biora Therapeutics, Inc.
California, United States
Patent: 1
King Abdulaziz University
Saudi Arabia
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 36 patents, we discovered top 4 universities and scientific research institutions by total patent application. Icahn School of Medicine at Mount Sinai, Baylor College of Medicine, Wuhan University are dominant in this area. They take 63.89% of the total patent filing.
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 8
Baylor College of Medicine
Texas, United States
Patent: 1
Wuhan University
Hubei Sheng, China
Patent: 1
King Abdulaziz University
Saudi Arabia
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: